Novel Therapeutic Approaches to Asthma in Clinical Medicine

Dear Colleagues,

Asthma is a chronic respiratory condition affecting millions globally. Despite advancements in treatment, it remains a significant cause of morbidity, leading to an ongoing search for more effective therapies.

Traditional treatments, such as inhaled corticosteroids and bronchodilators, have been the cornerstone of asthma management for decades. However, their limitations in addressing severe and treatment-resistant cases have led to the exploration of novel therapeutic approaches.

This Special Issue aims to explore cutting-edge treatments that go beyond traditional therapies, including biologics, personalized medicine, and innovative drug delivery systems. The goal is to enhance the effectiveness of asthma care and improve patient outcomes.

We are particularly interested in emerging treatments such as monoclonal antibodies targeting specific immune pathways, gene therapy, and microbiome-related interventions, all of which have shown promising results in early clinical trials.

We are soliciting original research articles, reviews, and other papers that focus on novel therapies for asthma. Papers that discuss new treatment modalities, biomarkers for therapy selection, and patient-centered approaches are particularly welcome.

Dr. Howraman Meteran
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.